Treating RET alterations with novel therapy BLU-667

Bookmark and Share
Published: 25 Apr 2018
Views: 4670
Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA

Dr Subbiah presents results at AACR 2018 from a first-in-human clinical trial of BLU-667 against RET alterations.

For more on this research, watch his interview with ecancer here.